| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article ![]()
Infection and Immunity, April 2000, p. 1773-1780, Vol. 68, No. 4
Max Planck Institute for Immunobiology,
Freiburg, Germany,1 and Department of
Immunology, Health Faculty, University of Cape Town, Cape Town, South
Africa2
Received 7 September 1999/Returned for modification 2 November
1999/Accepted 30 December 1999
We recently generated interleukin-4 (IL-4) receptor alpha-deficient
(IL-4R Experimental murine leishmaniasis is
a paradigm example for the relationship between the genetic factors
that control T helper cell differentiation and the outcome of the
disease. Healer strains like C57BL/6 develop dominant T helper 1 (Th1)
responses with high gamma interferon (IFN- In vitro, IL-12 and IL-4 were clearly shown to drive T helper
development toward the Th1 and Th2 phenotypes (26, 36, 53, 55), respectively. In vivo, the role of IL-4 for Th2 development has been studied extensively in murine leishmaniasis. Neutralization of
early Leishmania major-induced IL-4 production increases
resistance in BALB/c mice by promoting a protective Th1 response and
represses the development of a deleterious Th2 polarization (6,
50). It has been shown that a LACK antigen-specific
V We have recently generated an IL-4R Mice.
IL-4R Infection with L. major.
L. major LV 39 (MRHO/Sv/59/P strain) (40) was maintained by continuous
passage in mice. Parasites were isolated from skin lesions of infected
animals and grown in complete Iscove's modified Dulbecco's medium
(IMDM; Gibco, Paisley, Scotland) on rabbit blood agar as described
elsewhere (45). Anesthetized mice were infected subcutaneously into one hind footpad with 2 × 106 to
20 × 106 stationary-phase metacyclic L. major promastigotes (9) in a final volume of 50 µl of
Hanks' balanced salt solution. For intravenous infections, 2 × 107 promastigotes were used.
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Interleukin-4 Receptor Alpha-Deficient BALB/c Mice
Show an Unimpaired T Helper 2 Polarization in Response to
Leishmania major Infection

![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

/
) BALB/c mice and showed evidence for a
protective role of IL-13-mediated functions in leishmaniasis. In this
study, we investigated the IL-4 expression and T helper 2 (Th2)
development in Leishmania major-infected
IL-4R
/
mice. Here we show that the early burst of
IL-4 expression observed in L. major-infected BALB/c mice
is independent of IL-4R
-mediated functions. Subsequently, we
confirmed an impaired Th2 development in vitro. Unexpectedly, during
L. major infection, isolated CD4+
IL-4R
/
T cells expressed high IL-4- but low gamma
interferon (IFN-
)-specific mRNA, comparable to Th2-polarized BALB/c
CD4+ cells and in contrast to Th1-polarized C57BL/6
CD4+ cells. Since antigen-specific restimulated popliteal
lymph node cells (PLN) of IL-4R
/
mice also responded
with high IL-4 but low IFN-
production, comparable to Th2-polarized
cells from wild-type BALB/c mice and in contrast to Th1-polarized
C57BL/6 cells, these results suggested an unimpaired Th2 polarization
during an established infection with L. major. To further
define the observed IL-4 receptor-independent Th2 cell phenotype, we
determined an independent Th2 marker, the IL-12 receptor beta-2
(IL-12R
2)-specific transcript levels of CD4+ T cells.
Confirming Th2 polarization in L. major-infected
IL-4R
/
mice, comparable IL-12R
2 message levels
between CD4+ T cells from infected
IL-4R
/
mice and Th2 cells from BALB/c mice were
found, whereas Th1-polarized C57BL/6 cells showed strikingly increased
IL-12R
2 expression levels. These results indicate that signals
mediated by the IL-4R
are not necessary to induce and sustain an
efficient IL-4 expression and Th2 polarization in L. major-infected BALB/c mice and suggest that IL-4R
-independent
mechanisms underlie the default Th2 development in L. major-infected BALB/c mice.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
) production, low
interleukin-4 (IL-4) production, and protective cellular immune
responses, whereas nonhealer strains like BALB/c develop dominant Th2
responses with high IL-4 and low IFN-
production, resulting in
exacerbation of the disease (20, 39). This infectious
disease model has been particularly versatile to study the mechanisms
operating in vivo during the onset of T helper cell development from a
common pool of naive CD4+ T-cell precursors.
4+V
8+
CD4+ T-cell population is responsible for the early burst
of IL-4 and that depletion of this subpopulation renders BALB/c mice
resistant to the infection (33). The importance of IL-12 for
Th1 development in vivo has also been demonstrated in this infection
model. Mice on a genetically resistant background are rendered
susceptible to infection with L. major by the disruption of
IL-12 and mount a polarized Th2 cell response (40).
Moreover, treatment with IL-12 during the onset of the infection
increases resistance in BALB/c mice, skewing the T helper development
toward Th1 (22, 56). Recent in vitro studies have
demonstrated that Th2 commitment proceeds from a rapid loss of IL-12
responsiveness due to the down-regulation of the IL-12 receptor beta-2
chain (IL-12R
2) in BALB/c T cells (18, 57). Moreover,
L. major infection rapidly induces IL-12 unresponsiveness in
BALB/c mice (23, 35). Despite these accumulating data, the
role of IL-4 in driving BALB/c mice toward a dominant Th2 development
in L. major infection is not completely understood. It
remains elusive whether the enhanced IL-4 production or the rapidly
induced IL-12 unresponsiveness drive Th2 polarization in L. major-infected BALB/c mice.
-deficient mouse strain on a
genetically pure BALB/c background and demonstrated that both IL-4- and
IL-13-mediated functions were abrogated in the absence of IL-4R
.
IL-4R
/
mice showed an increased resistance to
infection with L. major, also observed in IL-4-deficient
BALB/c mice. In contrast to the latter, IL-4R
/
mice
eventually developed progressive disease, which indicates a protective
role for IL-13 in chronic leishmaniasis (45). The experiments presented here were designed to follow IL-4 expression and
T helper cell development in vivo in the absence of IL-4R
-mediated functions. IL-4R
/
mice are an ideal animal model to
address this question, since T helper development can be assessed on
the basis of expression of IL-4, the key effector cytokine of Th2
cells. Whereas in vitro Th2 development was strikingly impaired, in
vivo we found an unimpaired Th2 polarization in L. major-infected IL-4R
-deficient mice.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

/
mice were generated on a
pure BALB/c genetic background as recently described (45).
Mice were bred in specific-pathogen-free facilities and during
infection experiments were kept in filter top cages and maintained in
barrier facilities at the Max Planck Institute for Immunobiology
(Freiburg, Germany) or at the University of Cape Town (Cape Town, South Africa).
80°C and thawed at
37°C four times. F/T preparations were stored at
80°C until use.
Cell separation. (i) Fluorescence-activated cell sorting (FACS). Cells (1 × 107 to 5 × 107) were labeled and washed in PBS-3% fetal calf serum (FCS) at 4°C. Between each step of staining, cells were washed twice extensively. Labeling was performed with phycoerythrin-coupled anti-CD4 (RM4-5; PharMingen, San Diego, Calif.). To avoid nonspecific binding, cells were preincubated for 20 min with a cocktail of mouse and rat sera diluted 1/40 and unlabeled anti-CD32 (2.4G2) antibody. Cell sorting was performed on a FACStar (Becton Dickinson, Heidelberg, Germany) in buffer without NaN3 as recently described (8). Sorted cells were collected in complete IMDM with 20% FCS. The resulting CD4+ cell population were of >99% purity (data not shown).
(ii) Magnetic beads. Peripheral draining lymph nodes were purified for CD4+ cells by incubation with magnetic beads coated with anti-CD4 antibody RM4-5 (PharMingen), using the Dynabeads system as instructed by the manufacturer (Dynal, Oslo, Norway) as recently described (24). Subsequently, positively selected cells were detached from the beads. FACScan analysis of the resulting CD4+ cell population revealed >85% purity (data not shown).
In vitro CD4+ cell differentiation. (i) In vitro Th2
cell differentiation.
CD4+ T cells purified from lymph
nodes were cultured at 106/ml in flat-bottom microwells
(2 × 105/well) precoated with anti-CD3 (145-2C11; 10 µg/ml) and anti-CD28 (37/51; 10 µg/ml) and cultured in complete
IMDM supplemented with IL-2 (50 U/ml; PharMingen). T helper development
was driven by IL-12 (1 ng/ml; PharMingen), IL-4 (500 U/ml; PharMingen),
or IL-13 (25 pg/ml; R&D Systems) and neutralizing antibody for IL-4
(11B11; 10 µg/ml) or IFN-
(R4-6A2; 10 µg/ml) as indicated. After
72 h, cells were washed extensively, transferred to fresh
microwells, and cultured in the presence of IL-2 (50 U/ml) for 24 h. Finally, cells were transferred to microwells precoated with
anti-CD3. Cell-free supernatants were collected after 48 h of
culture without any additional reagents. Values represent means and
standard deviations of triplicate cultures.
(ii) L. major-specific restimulation. Restimulation of cells from draining lymph nodes of L. major-infected mice was performed as described previously (38). Briefly, cells (2 × 106 per well in 1 ml of complete IMDM) were stimulated in the presence of recombinant IL-2 (250 U/ml; PharMingen) with plate-bound anti-CD3 monoclonal antibody (145-2C11; 20 µg/ml) or 106 of F/T L. major antigen per ml in 48-well flat-bottom tissue culture plates. Supernatants were taken after 48 and 72 h of culture with anti-CD3 or L. major antigen, respectively. Cytokine levels in the supernatants were determined by enzyme-linked immunosorbent assay (ELISA). Values represent means and standard deviations of triplicate cultures.
RT-mediated PCR (RT-PCR).
RNA preparation, reverse
transcription, and PCR were performed as previously described (8,
29, 52). Briefly, total cellular RNA was prepared from spleen
cells or CD4+ popliteal lymph nodes (PLN), using RNA-Clean
(AGS, Heidelberg, Germany) according to the manufacturer's
instructions. Total RNA (3 µg) in a 30-µl reaction volume
containing random hexamer primers (50 pg/ml; Pharmacia, LKB, Freiburg,
Germany), 0.4 mM deoxynucleoside triphosphates (Promega, Heidelberg,
Germany), 50 mM Tris-HCl (pH 8.3), 75 mM KCl, and 3 mM
MgCl2 in the presence of 0.5 U of RNase inhibitor (Promega)
was reverse transcribed with murine Moloney leukemia virus reverse
transcriptase (RT; 16 U/ml; Gibco BRL, Gaithersburg, Md.). The reaction
mixture was incubated at 37°C for 90 min, terminated by heating to
94°C for 3 min, and immediately chilled on ice. Samples were diluted
1:10 with H2O to a concentration of 10 ng of cDNA
equivalents per ml, assuming a 1:1 ratio of reverse transcription.
Cycling conditions were 94°C for 2 min before 35 cycles of 94°C for
30 s, 56 to 62°C (depending on the primer pairs used) for
30 s, and 30 s at 72°C, followed by a final extension at
72°C for 3 min. Cycling conditions for the amplification of
2-microglobulin consisted of 32 cycles. PCR was performed using 0.2 U of Taq DNA polymerase (Stehelin AG, Basel, Switzerland) in
a total volume of 50 µl. Half of the PCR mixture was separated on a
1.6% agarose gel containing 0.2 µg of ethidium bromide per ml.
Quantification of cytokine transcripts.
The level of
individual transcripts was determined by competitive RT-PCR as
originally described (4), using the multispecific competitor
plasmids pMUS (54) for
2-microglobulin, IL-4, and IFN-
and pSPCR1 (27) for IL-4R
. Before quantification of
individual transcripts, cDNAs were adjusted to equal concentrations of
the housekeeping
2-microglobulin gene. PCR mixtures with equal
aliquots (usually 4 ml) of the diluted RT reaction containing
approximately 40 ng of cDNA equivalents and oligonucleotide-specific
primers were added to serial fourfold dilutions ranging from 5 × 106 to 75 molecules of the appropriate competitor plasmid
as previously described (8, 29, 52) and indicated in Fig. 3.
PCR coamplification was performed during the logarithmic phase, using
the cycling conditions described above. Specific primers compete for
binding on and amplification of the competitor control fragment and
cellular cDNA, resulting in fragments differing 50 to 100 bp in size.
The PCR products derived from the competitor template and the cDNA were
resolved on an agarose gel, and the relative ethidium bromide staining
intensities of the target and the competitor DNAs were compared. Equal
staining intensities in the competitive reaction indicates equal
concentrations, allowing quantification of the input cDNA. In all
experiments, control PCR with competitor only or without DNA was
performed to exclude false positives.
2-specific cDNA was amplified for 30 cycles with the primers
IL-12R
2-s (5'-CTGCACCCACTCACATTAAC-3') and IL-12R
2-as (5'-CAGTTGGCTTTGCCCTGTGG-3'), amplifying a 670-bp product.
No specific products were obtained when reverse transcription was omitted or genomic DNA was used as the template.
Densitometric analysis was performed using the computer-based image
software NIH Image 1.52 (National Institutes of Health, Bethesda, Md.)
and measured as pixels per square millimeter.
ELISA.
Cytokine levels in culture supernatants were detected
by sandwich ELISA as described before (7). Supernatants and
appropriate cytokine standards (PharMingen) were used in threefold
serial dilutions. The coating and biotinylated detection antibodies for IFN-
and IL-4 were purchased from PharMingen. Detection was
performed with alkaline phosphatase-coupled streptavidin (Southern
Biotechnology, Birmingham, Ala.). The detection limits for IFN-
and
IL-4 were 0.2 and 0.01 ng/ml, respectively.
| |
RESULTS |
|---|
|
|
|---|
IL-4R
-independent IL-4 expression during early L. major infection.
L. major induces a burst of IL-4 mRNA
expression in the spleen cells of BALB/c mice 90 min after intravenous
infection. The source are CD4+ T cells that express a
canonical V
4+V
8+
T-cell receptor repertoire (33). Using
IL-4R
/
mice, we intended to determine if this early
burst of IL-4 expression is independent on a IL-4R
-mediated
stimulation by IL-4 and repeated the original experiments, including
IL-4R
-deficient mice. IL-4R
/
, BALB/c, and C57BL/6
mice were infected intravenously with 107 L. major LV 39 (MRHO/Sv/59/P strain) metacyclic promastigotes. Ninety
minutes later, mice were sacrificed, total RNA was extracted, and an
aliquot was reverse transcribed from individual spleens as described in
Materials and Methods. After adjusting the individual cDNA samples to
equal concentrations for the housekeeping
2-microglobulin gene, the
level of IL-4-specific mRNA expression was quantified by competitive
RT-PCR and compared with mRNA levels from uninfected mice (Fig.
1). Spleen cells from infected BALB/c
mice showed an increase of IL-4 message in comparison to uninfected
BALB/c mice. In contrast, infected C57BL/6 cells showed reduced IL-4
mRNA levels compared to uninfected controls, confirming previous
results (33). Spleen cells from infected
IL-4R
/
BALB/c mice showed also a similar increase of
IL-4 message in comparison to uninfected BALB/c mice, therefore
reflecting the phenotype of BALB/c mice but not C57BL/6 mice. As
suggested from published BALB/c studies (35), our results
demonstrate that the early IL-4 expression induced by L. major infection in BALB/c mice can be independent of signals
mediated by IL-4R
.
|
IL-4R
-independent IL-4 production during an established L. major infection.
To investigate the in vivo T helper
development in the absence of a functional IL-4 receptor, we performed
acute L. major infection studies and determined the
differentiation of Th1 versus Th2 cells were.
IL-4R
/
, BALB/c, and C57BL/6 mice were infected with
2 × 107 L. major LV 39 (MRHO/Sv/59/P
strain) metacyclic promastigotes into one hind footpad. The course of
infection was monitored by measuring the swelling of the infected
footpad weekly (data not shown). At day 56 postinfection, at a time
point where T helper cell polarization is known to be established,
animals were sacrificed and the draining PLN were isolated. To reveal
the cytokine expression profile, cells were restimulated by the
addition of either anti-CD3 or Leishmania antigen for 48 or
72 h, and cytokine concentration in supernatants were measured by
ELISA (Fig. 2). After polyclonal T-cell
restimulation with anti-CD3, IFN-
concentrations were low in
supernatants from BALB/c and IL-4R
/
cultures but
high in cultures of PLN from infected C57BL/6 mice. IL-4 concentrations
were relatively high in supernatants from cultures of all three
strains.
|
levels and undetectable IL-4, whereas BALB/c cultures had at least 50-fold-higher IL-4 and 5-fold-lower IFN-
concentrations,
demonstrating a type 2 polarization. Interestingly,
IL-4R
/
mice showed a type 2 cytokine profile
comparable to that of BALB/c mice after antigen-specific restimulation
of PLN. Similar results were found at 10 and 18 weeks after infection
with 2 × 106 promastigotes into one hind footpad
(Table 1). At the latter time point,
antigen-specific IL-4 production was undetectable, with high IFN-
concentrations in BALB/c or IL-4R
/
mice. A similar
Th1 response in late infection of BALB/c mice was recently observed by
others (5). Taken together, these experiments demonstrate
that a sustained IL-4 production can be independent of
IL-4R
-mediated function in L. major-primed BALB/c lymphocytes. Moreover, the lack of a functional IL-4 receptor results
in no increased production of IFN-
and therefore no skewed Th1
response. Conclusively, our observations suggest an
IL-4R
-independent, highly efficient mechanism for type 2 differentiation in L. major-infected BALB/c mice.
|
An unimpaired Th2 polarization in L. major-infected
IL-4R
/
BALB/c mice.
To determine in vivo T
helper polarization of CD4+ cells, omitting in vitro
restimulation, we assessed gene transcription by RT-PCR. We infected
IL-4R
/
, BALB/c, and C57BL/6 mice with 2 × 106 L. major promastigotes (45) and
isolated CD4+ T cells from PLN 49 days after infection by
anti-CD4-coupled magnetic beads. RNA was extracted, and IL-4- and
IFN-
-specific message was quantified by competitive RT-PCR after
adjusting the cDNAs, using the constitutive housekeeping
2-microglobulin gene as a standard (Fig.
3). Quantitative analysis showed that
CD4+ T cells from infected C57BL/6 mice expressed
eightfold-higher IFN-
-specific transcript levels and at least
eightfold-lower IL-4-specific transcript levels compared with BALB/c
mice (Fig. 3a and b). These results were consistent with our
antigen-specific restimulation experiments and confirm earlier studies
(3, 20, 39), demonstrating a dominant Th1 phenotype in
resistant C57BL/6 mice but a dominant Th2 phenotype in susceptible
BALB/c mice. IL-4R
/
CD4+ cells showed
IFN-
- and IL-4-specific transcript levels comparable to those of
Th2-differentiated BALB/c CD4+ cells (Fig. 3a and b). The
unimpaired Th2 phenotype of IL-4R
/
CD4+
T cells in comparison to BALB/c controls was unexpected, as it is
believed that IL-4 is the factor responsible for Th2 differentiation in
leishmaniasis. Hence, we determined CD4+ T cells for an
independent marker that is regulated in a T helper-specific manner.
IL-12R
2 is expressed very early during T-cell activation. It is
subsequently down-regulated on developing Th2 cells, rendering them
unresponsive to IL-12, whereas it remains expressed on Th1 cells in
vitro (57). This down-regulation has also been observed in
vivo after infection of BALB/c mice with L. major (23,
35). Indeed, as shown in Fig. 3c, the levels of
IL-12R
2-specific mRNA of Th2-differentiated BALB/c CD4+
cells were strikingly (threefold) lower than those of
Th1-differentiated C57BL/6 cells. Comparable low levels of IL-12R
2
transcription levels were found in CD4+ cells from
IL-4R
/
and BALB/c mice, confirming the presence of
Th2-polarized cells in infected IL-4R
/
mice. The
expression levels of IL-4R
were similar in Th1-polarized cells of
C57BL/6 mice and Th2 cells of BALB/c mice (Fig. 3c), indicating that
the loss of IL-4 responsiveness does not underlie differential IL-4
receptor expression in BALB/c mice.
|
Impaired in vitro Th2 differentiation in the absence of
IL-4R
.
IL-4 induces the differentiation of naive Th cells into
Th2 cells in vitro (36, 55), whereas Th1 development is
driven by IL-12 (53). Since the in vivo L. major
studies showed an unimpaired Th2 cell phenotype in
IL-4R
/
mice, the in vitro potential of naive
IL-4R
/
T cells to differentiate into Th1/Th2 cells
was investigated. Unprimed CD4+ lymph node cells from
IL-4R
/
mice and wild-type controls were isolated by
FACS, subsequently cultured with anti-CD3/CD28 in the presence of IL-2,
and stimulated with a combination of either IL-12 and anti-IL-4 to
induce Th1 development or IL-4 and anti-IFN-
to induce Th2
development. IL-4R
/
CD4+ T cells showed
normal Th1 differentiation, as indicated by their ability to produce
high amounts of IFN-
but low levels of IL-4, similarly to wild-type
cells, following IL-12-anti-IL-4 stimulation (Fig.
4). In contrast,
IL-4R
/
CD4+ T cells showed impaired in
vitro Th2 differentiation, determined by >2-fold-higher IFN-
but
>10-fold-lower IL-4 production compared to IL-4-stimulated wild-type
cells (Fig. 4). IL-13 in combination with anti-IFN-
had no major
effect on T helper differentiation since both IFN-
and IL-4 levels
remained low in wild-type cells.
|
| |
DISCUSSION |
|---|
|
|
|---|
L. major infection studies in IL-4R
/
BALB/c mice demonstrated that the early burst of endogenous IL-4
expression in BALB/c mice is independent of stimulation by its own
receptor but directly induced by Leishmania, confirming
previous infection studies in BALB/c mice (34). Depletion
studies have shown that the source of early IL-4 production is a T-cell
receptor-restricted LACK antigen-specific
V
4+V
8+
CD4+ T-cell population. Its depletion also abrogates Th2
development (33).
The main finding in this study was an unimpaired Th2 polarization in
L. major-infected IL-4R
/
mice during an
established infection. We demonstrated the presence of a Th2 cell
phenotype by all analyzed criteria of CD4+ T cells: high
IL-4 but low IFN-
and IL-12R
2 transcript and/or protein
expression levels comparable to Th cells of infected BALB/c controls at
6 and 8 weeks in infected IL-4R
/
BALB/c mice. These
results clearly demonstrate that L. major-specific Th2 cells
are able to develop efficiently in the absence of IL-4 (or
IL-13)-mediated functions. This was unexpected, as it is believed that
the Th2-promoting influence of IL-4 is responsible for driving Th2
development in L. major-infected BALB/c mice, a conclusion based mainly on IL-4 neutralization studies. Despite our finding of an
unimpaired Th2 polarization in an established infection, an influence
of endogenous IL-4 on Th2 cell differentiation in L. major-infected mice, which may be more evident in earlier time points during the course of infection, cannot be excluded. Indeed, in a
recent study, L. major-infected IL-4R
/
BALB/c mice showed a reduction of IL-4-specific message in draining lymph nodes compared to BALB/c controls at 56 days postinfection (46). However, since data were obtained from unseparated
PLN, the observed twofold reduction could be also due to a lack of IL-4-mediated downstream effector functions on CD4-negative cells rather than reduced IL-4 expression in T helper cells. Irrespective of
the influence of endogenous IL-4 on L. major-induced Th2
differentiation, the question arises as to the mechanism(s) responsible
for the observed efficient IL-4 (or IL-13)-independent L. major-specific Th2 cell differentiation. Possible answers may
inferred from recent studies which showed a cell-intrinsic bias toward
IL-4 expression of activated CD4+ BALB/c T cells (17,
25). This genetically linked commitment has been demonstrated to
be independent of signals mediated by the IL-4 receptor (2);
therefore, it is possible that the high parasite burden in the draining
lymph nodes of L. major-infected in BALB/c mice
(45) itself is the driving force of the sustained activation
of CD4+ Th2 cells, with subsequent transcription of IL-4 in
chronically infected IL-4R
/
BALB/c mice. In
addition, the dominant IL-4 phenotype could be exacerbated by
conversion of L. major-specific Th1 cells (43) by
L. major-infected and/or antigen-presenting cells
(44) in the absence of IL-4-mediated functions or due to a
lack of signals inducing a Th1 development. Indeed, we did not observe
an increased Th1 response, and CD4+ T cells from wild-type
and IL-4R
/
BALB/c mice showed strikingly reduced
levels of 12R
2-specific message in comparison to C57BL/6 cells.
IL-12 is the key promoting cytokine for Th1 development and antagonizes
Th2-promoting cells. Therefore, the observed impaired IL-12
responsiveness by down-regulation of the IL-12 receptor may have
favored Th2 differentiation of activated T cells in the mutant mice.
This possible explanation is in agreement with the recent
identification of a locus on chromosome 11 which seems to be involved
in premature loss of functional IL-12 receptor expression, as one
mechanism underlying the BALB/c bias (16, 19).
Down-regulation of IL-12R
2 expression is also believed to depend on
IL-4, since it can be prevented by the administration of IL-4
neutralizing antibodies (23, 35). The reduced IL-12R
2 expression levels of IL-4R
/
BALB/c CD4+
cells (in comparison to corresponding cells from C57BL/6
CD4+) clearly suggest that other (IL-4-independent)
mechanisms must exist in addition.
The presence of an effective IL-4 receptor-independent Th2
differentiation pathway seems to be specific for L. major
infection, as impaired Th2 differentiation was observed in
IL-4R
/
mice infected with Nippostrongylus
brasiliensis (1, 46). IL-4R
/
mice
showed an even more severe impairment of the Th2 differentiation compared to infected IL-4-deficient mice, suggesting a regulatory role
for the IL-13 on Th2 cell development (1). Similar
observations were also made in IL-13- or IL-4/IL-13-deficient mice
(41, 42). The molecular mechanisms for these IL-13-mediated
functions are elusive, and direct IL-13 effects on T cells cannot be
completely ruled out. Indirect regulatory effects are possible since
IL-13, like IL-4, has potent modulating effects on macrophages, such as
the secretion of NO, which is known to be protective against L. major, or IL-12 and IL-18 production. Both cytokines influence Th1
differentiation (48, 58), and their potential deregulation due to the absence of IL-13-mediated functions may alter T helper development in vivo. It should be noted that these IL-13 functions could potentially still be mediated in IL-4R
/
mice
by the recently cloned IL-13R
2 (10). Since neither
exogenous IL-13 nor IL-4 can restore wild-type responses in T cells
derived from IL-13
/
mice (41), IL-13 seems
to act upstream of IL-4 on T cells. Mechanistically, IL-13 could
modulate the common signal transduction pathways of IL-4 and IL-13,
including the IL-4 receptor itself.
The observation of an impairment of in vitro Th2 differentiation is
consistent with earlier studies (36, 53), and analysis in
mice deficient in IL-4 (30, 32) or IL-4R
(46)
demonstrate that IL-4 is the promoting factor for Th2 differentiation
in vitro. The absence of IL-13-driven Th2 differentiation (Fig. 4) is
also consistent with studies showing that in contrast to human T cells, murine T cells are not responsive to IL-13 stimulation (60). It is worth noting that despite the absence of the IL-4 receptor, diminished but still measurable production of IL-4 was detected in the
supernatants of stimulated IL-4R
/
lymph node cells
irrespective of the stimuli used (Fig. 4). These results show that also
in vitro IL-4 production can continue independently of IL-4R
signaling as previously suggested (46), and IL-4-independent Th2 differentiation can be a major pathway as demonstrated in the study
presented here.
The different outcome between L. major-infected
IL-4R
/
mice and anti-IL-4 neutralization studies
prompted us to reexamine common literature data. Interestingly, most of
the original neutralization studies determined type 2 responses rather
than Th2 differentiation, showing reduced immunoglobulin E production
(31) and/or reduced IL-4 production in lymph node cells
(5, 6), and an effect of anti-IL-4 treatment on PLN IL-4
expression was not always found (37). More important, in
those rare anti-IL-4 experiments where Th2 differentiation was directly
investigated using isolated CD4+ T cells, a reduction of
IL-4 mRNA expression levels was originally found in Northern analysis
(21, 50). However, a recent study using a more sensitive
semiquantitative RT-PCR study could not confirm these previous findings
with similar expression levels in anti-IL-4-treated and untreated
BALB/c CD4+ T cells (47). In addition to the
varying neutralization data, we should be aware that both approaches
have their limits and may induce unknown alternative pathways. In the
gene-deficient mouse model, mice develop in the absence of IL-4 (and
IL-13)-mediated functions; hence alternative pathways, inactive in
IL-4-producing wild-type mice, cannot be excluded. Moreover, soluble
IL-4R
is also absent in IL-4R
/
mice
(45) but abundantly present in BALB/c mice (51),
with increased expression levels in L. major-infected mice
(12). Since both antagonistic and agonistic functions, which
seem to depend on the relative concentration on IL-4 and soluble
IL-4R
, have been demonstrated (14, 15, 28), some unknown
effects of soluble IL-4R
on T helper differentiation in BALB/c mice
cannot be ruled out. Anti-IL-4 neutralization, on the other hand, is effective only during the first 2 days after infection (35). Moreover, as discussed above, Th2 responses vary and other effects from
the antibody treatment cannot be ruled out. For example, incomplete
neutralization is probably unavoidable in autocrine stimulation
pathways due to the close proximity of the ligand to the receptor, as
is the case for IL-4-producing Th2 cells, and resulting partial
signaling may alter T helper cell responses in vivo. Second, the
anti-IL-4 antibody (11B11) used for neutralization studies has also
stabilization properties on IL-4 in vivo, with altering effects on the
kinetics of biodistribution of endogenous IL-4 (51). This
may have consequences on in vivo T helper differentiation. Also, the
demonstrated interrelationship between anti-IL-4 treatment and soluble
IL-4R
(11, 13, 49) may influence T helper
differentiation. Therefore, some other (unknown) mechanisms due to
these cytokine-binding proteins could be responsible for the observed
Th2 polarization in IL-4-neutralized BALB/c mice. To investigate the
possible effects of soluble IL-4R
in L. major and Th2
differentiation, we are in the process of generating a mouse strain
deficient for soluble IL-4R
induced by alternative transcription.
In summary, our results show that signals mediated by the IL-4R
are
not necessary to induce and sustain IL-4 expression whereas IFN-
production remains low in CD4+ cells. Hence, an efficient
IL-4R
-independent Th2-polarizing mechanism must exist that underlies
the default Th2 development in L. major-infected BALB/c mice.
| |
ACKNOWLEDGMENTS |
|---|
We thank B. Arendse, M. Held, M. Simpson, and K.-H. Widmann for excellent technical assistance, H. Mossmann and H. Arendse for organization of the animal facility, J. C. Gutierrez-Ramos for obtaining the competitor plasmid pSPCR1, and G. Alber, M. Kopf, and A. Gessner for stimulating discussions and critical reviews of the manuscript.
This work was supported by the German-Israeli Foundation (grant I-260-162.02/92) and by the Medical Research Centre, South Africa (grant 415509). F.B. is holder of a Wellcome Senior Research Fellowship in Medical Science in South Africa.
| |
ADDENDUM IN PROOF |
|---|
Since acceptance of the manuscript, we have shown that the adjuvant alum can drive a Th2 response independently of signaling through the interleukin-4 receptor alpha (J. M. Brewer, M. Conacher, C. A. Hunter, M. Mohrs, F. Brombacher, and J. Alexander, J. Immunol. 163:6448-6454, 1999).
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: University of Cape Town, Groote Schuur Hospital, Medical Faculty, Immunology Department, OMB, H47, Observatory, 7925, Cape Town, South Africa. Phone: (27)-21-4044013. Fax: (27)-21-4486116. E-mail: fbrombac{at}uctgsh1.uct.ac.za.
Present address: Howard Hughes Medical Institute and Department of
Medicine and Microbiology/Immunology, University of California, San
Francisco, San Francisco, Calif.
Editor: W. A. Petri Jr.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Barner, M.,
M. Mohrs,
F. Brombacher, and M. Kopf.
1998.
Differences between IL-4R and IL-4 deficient mice reveal a novel role of IL-13 in the regulation of T helper 2 cells and protection to nematode infection.
Curr. Biol.
8:669-672[CrossRef][Medline].
|
| 2. |
Bix, M.,
Z. E. Wang,
B. Thiel,
N. J. Schork, and R. M. Locksley.
1998.
Genetic regulation of commitment to interleukin 4 production by a CD4(+) T cell-intrinsic mechanism.
J. Exp. Med.
188:2289-2299 |
| 3. | Bogdan, C., A. Gessner, and M. Rollinghoff. 1993. Cytokines in leishmaniasis: a complex network of stimulatory and inhibitory interactions. Immunobiology 189:356-396[Medline]. |
| 4. |
Bouaboula, M.,
P. Legoux,
B. Pessegue,
B. Delpech,
X. Dumont,
M. Piechaczyk,
P. Casellas, and D. Shire.
1992.
Standardization of mRNA titration using a polymerase chain reaction method involving co-amplification with a multispecific internal control.
J. Biol. Chem.
267:21830-21838 |
| 5. | Chatelain, R., S. Mauze, K. Varkila, and R. L. Coffman. 1999. Leishmania major infection in interleukin-4 and interferon-gamma depleted mice. Parasite Immunol. 21:423-431[CrossRef][Medline]. |
| 6. | Chatelain, R., K. Varkila, and R. L. Coffman. 1992. IL-4 induces a Th2 response in Leishmania major-infected mice. J. Immunol. 148:1182-1187[Abstract]. |
| 7. | Dai, W. D., G. Köhler, and F. Brombacher. 1997. Both innate and acquired immunity to Listeria monocytogenes infection are increased in IL-10 deficient mice. J. Immunol. 158:2259-2267[Abstract]. |
| 8. |
Dai, W. J.,
W. Bartens,
G. Köhler,
M. Hufnagel,
M. Kopf, and F. Brombacher.
1997.
Impaired macrophage listericidal and cytokine activities are responsible for the rapid death of Listeria monocytogenes-infected IFN- receptor-deficient mice.
J. Immunol.
158:5297-5304[Abstract].
|
| 9. |
Da Silva, R., and D. L. Sacks.
1987.
Metacyclogenesis is a major determinant of Leishmania promastigote virulence and attenuation.
Infect. Immun.
55:2802-2806 |
| 10. |
Donaldson, D. D.,
M. J. Whitters,
L. J. Fitz,
T. Y. Neben,
H. Finnerty,
S. L. Henderson,
R. J. O'Hara,
D. R. Beier,
K. J. Turner,
C. R. Wood, and M. Collins.
1998.
The murine IL-13 receptor alpha 2: molecular cloning, characterization, and comparison with murine IL-13 receptor alpha 1.
J. Immunol.
161:2317-2324 |
| 11. | Fanslow, W. C., K. N. Clifford, L. S. Park, A. S. Rubin, R. F. Voice, M. P. Beckmann, and M. B. Widmer. 1991. Regulation of alloreactivity in vivo by IL-4 and the soluble IL-4 receptor. J. Immunol. 147:535-540[Abstract]. |
| 12. | Fernandez, B. R., P. M. Chilton, B. D. Hondowicz, J. Vetvickova, J. Yan, W. Jones III, and P. Scott. 1999. Regulation of the production of soluble IL-4 receptors in murine cutaneous leishmaniasis. The roles of IL-12 and IL-4. J. Leukoc. Biol. 66:481-488[Abstract]. |
| 13. | Fernandez, B. R., T. A. Wynn, S. Hieny, P. Caspar, P. M. Chilton, and A. Sher. 1995. Linked in vivo expression of soluble interleukin-4 receptor and interleukin-4 in murine schistosomiasis. Eur. J. Immunol. 25:649-656[Medline]. |
| 14. | Fernandez-Botran, R., P. M. Chilton, Y. Ma, J. L. Windsor, and N. E. Street. 1996. Control of the production of soluble interleukin-4 receptors: implications in immunoregulation. J. Leukoc. Biol. 59:499-504[Abstract]. |
| 15. |
Gessner, A.,
K. Schroppel,
A. Will,
K. H. Enssle,
L. Lauffer, and M. Rollinghoff.
1994.
Recombinant soluble interleukin-4 (IL-4) receptor acts as an antagonist of IL-4 in murine cutaneous leishmaniasis.
Infect. Immun.
62:4112-4117 |
| 16. |
Gorham, J. D.,
M. L. Guler,
R. G. Steen,
A. J. Mackey,
M. J. Daly,
K. Frederick,
W. F. Dietrich, and K. M. Murphy.
1996.
Genetic mapping of a murine locus controlling development of T helper 1/T helper 2 type responses.
Proc. Natl. Acad. Sci. USA
93:12467-12472 |
| 17. |
Guery, J. C.,
F. Galbiati,
S. Smiroldo, and L. Adorini.
1996.
Selective development of T helper (Th) 2 cells induced by continuous administration of low dose soluble proteins to normal and beta(2)-microglobulin-deficient BALB/c mice.
J. Exp. Med.
183:485-497 |
| 18. | Guler, M. L., J. D. Gorham, C. S. Hsieh, A. J. Mackey, R. G. Steen, W. F. Dietrich, and K. M. Murphy. 1996. Genetic susceptibility to Leishmania: IL-12 responsiveness in TH1 cell development. Science 271:984-987[Abstract]. |
| 19. | Guler, M. L., N. G. Jackobson, U. Gubler, and K. M. Murphy. 1997. T cell genetic background determines maintenance of IL-12 signaling. Effects on Balb/c and B10.D2 T helper cell type 1 phenotype development. J. Immunol. 159:1767-1774[Abstract]. |
| 20. |
Heinzel, F. P.,
M. D. Sadick,
B. J. Holaday,
R. L. Coffman, and R. M. Locksley.
1989.
Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets.
J. Exp. Med.
169:59-72 |
| 21. |
Heinzel, F. P.,
M. D. Sadick,
S. S. Mutha, and R. M. Locksley.
1991.
Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis.
Proc. Natl. Acad. Sci. USA
88:7011-7015 |
| 22. |
Heinzel, F. P.,
D. S. Schoenhaut,
R. M. Rerko,
L. E. Rosser, and M. K. Gately.
1993.
Recombinant interleukin 12 cures mice infected with Leishmania major.
J. Exp. Med.
177:1505-1509 |
| 23. |
Himmelrich, H.,
L. C. Parra,
C. F. Tacchini,
J. A. Louis, and P. Launois.
1998.
The IL-4 rapidly produced in BALB/c mice after infection with Leishmania major down-regulates IL-12 receptor beta 2-chain expression on CD4+ T cells resulting in a state of unresponsiveness to IL-12.
J. Immunol.
161:6156-6163 |
| 24. |
Hölscher, C.,
G. Köhler,
U. Müller,
H. Mossmann,
G. A. Schaub, and F. Brombacher.
1997.
Defective nitric oxide effector functions lead to extreme susceptibility of Trypanosoma cruzi-infected mice deficient in gamma interferon receptor or inducible nitric oxide synthase.
Infect. Immun.
66:1208-1215 |
| 25. |
Hsieh, C. S.,
S. E. Macatonia,
A. O'Garra, and K. M. Murphy.
1995.
T cell genetic background determines default T helper phenotype development in vitro.
J. Exp. Med.
181:713-721 |
| 26. |
Hsieh, C. S.,
S. E. Macatonia,
C. S. Tripp,
S. F. Wolf,
A. O'Garra, and K. M. Murphy.
1993.
Development of T(H)1 CD4(+) T cells through IL-12 produced by Listeria-induced macrophages.
Science
260:547-549 |
| 27. | Jia, G. Q., and J. C. Gutierrez-Ramos. 1995. Quantitative measurement of mouse cytokine mRNA by polymerase chain reaction. Eur. Cytokine Netw. 6:253-255[Medline]. |
| 28. | Jung, T., K. Wagner, C. Neumann, and C. H. Heusser. 1999. Enhancement of human IL-4 activity by soluble IL-4 receptors in vitro. Eur. J. Immunol. 29:864-871[CrossRef][Medline]. |
| 29. |
Kopf, M.,
F. Brombacher,
G. Köhler,
G. Kienzle,
K.-H. Widmann,
K. Lefrang,
C. Humborg,
B. Ledermann, and W. Solbach.
1996.
IL-4-deficient Balb/c mice resist infection with Leishmania major.
J. Exp. Med.
184:1127-1136 |
| 30. | Kopf, M., G. G. Le, M. Bachmann, M. C. Lamers, H. Bluethmann, and G. Koehler. 1993. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 362:245-248[CrossRef][Medline]. |
| 31. | Kropf, P., R. Etges, L. Schopf, C. Chung, J. Sypek, and I. Muller. 1997. Characterization of T cell-mediated responses in nonhealing and healing Leishmania major infections in the absence of endogenous IL-4. J. Immunol. 159:3434-3443[Abstract]. |
| 32. |
Kuhn, R.,
K. Rajewsky, and W. Muller.
1991.
Generation and analysis of interleukin-4 deficient mice.
Science
254:707-710 |
| 33. | Launois, P., I. Maillard, S. Pingel, K. G. Swihart, I. Xenarios, O. H. Acha, H. Diggelmann, R. M. Locksley, H. R. MacDonald, and J. A. Louis. 1997. IL-4 rapidly produced by V beta 4 V alpha 8 CD4+ T cells instructs Th2 development and susceptibility to Leishmania major in BALB/c mice. Immunity 6:541-549[CrossRef][Medline]. |
| 34. |
Launois, P.,
T. Ohteki,
K. Swihart,
H. R. MacDonald, and J. A. Louis.
1995.
In susceptible mice, Leishmania major induce very rapid interleukin-4 production by CD4+ T cells which are NK1.1 .
Eur. J. Immunol.
25:3298-3307[Medline].
|
| 35. | Launois, P., K. G. Swihart, G. Milon, and J. A. Louis. 1997. Early production of IL-4 in susceptible mice infected with Leishmania major rapidly induces IL-12 unresponsiveness. J. Immunol. 158:3317-3324[Abstract]. |
| 36. |
Le Gros, G.,
S. S. Ben,
R. Seder,
F. D. Finkelman, and W. E. Paul.
1990.
Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells.
J. Exp. Med.
172:921-929 |
| 37. | Li, J., P. Scott, and J. P. Farrell. 1996. In vivo alterations in cytokine production following interleukin-12 (IL-12) and anti-IL-4 antibody treatment of CB6F1 mice with chronic cutaneous leishmaniasis. Infect. Immun. 64:5248-5254[Abstract]. |
| 38. |
Locksley, R.,
S. L. Reiner,
F. Hatam,
D. R. Littman, and N. Killeen.
1993.
Helper T cells without CD4: control of leishmaniasis in CD4-deficient mice.
Science
261:1448-1451 |
| 39. | Locksley, R. M., F. P. Heinzel, B. J. Holaday, S. S. Mutha, S. L. Reiner, and M. D. Sadick. 1991. Induction of Th1 and Th2 CD4+ subsets during murine Leishmania major infection. Res. Immunol. 142:28-32[CrossRef][Medline]. |
| 40. | Mattner, F., J. Magram, J. Ferrante, P. Launois, P. K. Di, R. Behin, M. K. Gately, J. A. Louis, and G. Alber. 1996. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response. Eur. J. Immunol. 26:1553-1559[Medline]. |
| 41. | McKenzie, G. J., C. L. Emson, S. E. Bell, S. Anderson, P. Fallon, G. Zurawski, R. Murray, R. Grencis, and A. N. McKenzie. 1998. Impaired development of Th2 cells in IL-13-deficient mice. Immunity 9:423-432[CrossRef][Medline]. |
| 42. |
McKenzie, G. J.,
P. Fallon,
C. L. Emson,
R. Grencis, and A. N. McKenzie.
1999.
Simultaneous disruption of Interleukin (IL)-4 and IL-13 defines individual roles in T helper cell type 2-mediated responses.
J. Exp. Med.
189:1565-1572 |
| 43. | Mocci, S., and R. L. Coffman. 1995. Induction of a Th2 population from a polarized Leishmania-specific Th1 population by in vitro culture with IL-4. J. Immunol. 154:3779-3787[Abstract]. |
| 44. | Mocci, S., and R. L. Coffman. 1997. The mechanism of in vitro T helper cell type 1 to T helper cell type 2 switching in highly polarized Leishmania major-specific T cell populations. J. Immunol. 158:1559-1564[Abstract]. |
| 45. |
Mohrs, M.,
B. Lederman,
G. Koehler,
A. Dorfmueller,
A. Gessner, and F. Brombacher.
1999.
Differences between IL-4 and IL-4R deficient mice in chronic leishmaniasis reveal a protective role for IL-13 receptor signaling.
J. Immunol.
162:7302-7308 |
| 46. |
Noben-Trauth, N.,
L. D. Shultz,
F. Brombacher,
J. F. Urban,
H. Gu, and W. E. Paul.
1997.
An interleukin 4 (IL-4)-independent pathway for CD4+ T cell IL-4 production is revealed in IL-4 receptor-deficient mice.
Proc. Natl. Acad. Sci. USA
94:10838-10843 |
| 47. | Noben-Trauth, N. P., P. Kropf, and I. Mueller. 1996. Susceptibility to Leishmania major infection in interleukin-4-deficient mice. Science 271:987-990[Abstract]. |
| 48. |
Okamura, H.,
S.-I. Kashiwamura,
H. Tsutsui,
T. Yoshimoto, and K. Nakanishi.
1998.
Regulation of interferon- production by IL-12 and IL-18.
Curr. Opin. Immunol.
10:529.
|
| 49. | Rudolphi, A., K. H. Enssle, M. H. Claesson, and J. Reimann. 1993. Adoptive transfer of low numbers of CD4+ T cells into SCID mice chronically treated with soluble IL-4 receptor does not prevent engraftment of IL-4-producing T cells. Scand. J. Immunol. 38:57-64[CrossRef][Medline]. |
| 50. |
Sadick, M. D.,
F. P. Heinzel,
B. J. Holaday,
R. T. Pu,
R. S. Dawkins, and R. M. Locksley.
1990.
Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism.
J. Exp. Med.
171:115-127 |
| 51. | Sato, T. A., M. B. Widmer, F. D. Finkelman, H. Madani, C. A. Jacobs, K. H. Grabstein, and C. R. Maliszewski. 1993. Recombinant soluble murine IL-4 receptor can inhibit or enhance IgE responses in vivo. J. Immunol. 150:2717-2723[Abstract]. |
| 52. | Satoskar, A., F. Brombacher, W. J. Dai, I. McInnes, F. Y. Liew, J. Alexander, and W. Walker. 1997. SCID mice reconstituted with IL-4-deficient lymphocytes, but not immunocompetent lymphocytes, are resistant to cutaneous leishmaniasis. J. Immunol. 159:5005-5013[Abstract]. |
| 53. |
Seder, R. A.,
R. Gazzinelli,
A. Sher, and W. E. Paul.
1993.
Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming.
Proc. Natl. Acad. Sci. USA
90:10188-10192 |
| 54. | Shire, D. 1993. Open exchange of reagents and information useful for the measurement of cytokine mRNA levels by PCR. Eur. Cytokine Netw. 4:161-162. |
| 55. | Swain, S. L., A. D. Weinberg, M. English, and G. Huston. 1990. IL-4 directs the development of Th2-like helper effectors. J. Immunol. 145:3796-3806[Abstract]. |
| 56. |
Sypek, J. P.,
C. L. Chung,
S. E. Mayor,
J. M. Subramanyam,
S. J. Goldman,
D. S. Sieburth,
S. F. Wolf, and R. G. Schaub.
1993.
Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response.
J. Exp. Med.
177:1797-1802 |
| 57. |
Szabo, S. J.,
A. S. Dighe,
U. Gubler, and K. M. Murphy.
1997.
Regulation of the interleukin (IL)-12R beta2 subunit expression in developing T helper 1 (Th1) and Th2 cells.
J. Exp. Med.
185:817-824 |
| 58. | Takeda, K., H. Tsutsui, T. Yoshimoto, O. Adachi, N. Yoshida, T. Kishimoto, H. Okamura, K. Nakanishi, and S. Akira. 1998. Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 8:383-390[CrossRef][Medline]. |
| 59. | Titus, R. G., R. Ceredig, J. C. Cerottini, and J. A. Louis. 1985. Therapeutic effect of anti-L3T4 monoclonal antibody GK1.5 on cutaneous leishmaniasis in genetically-susceptible BALB/c mice. J. Immunol. 135:2108-2114[Abstract]. |
| 60. | Zurawski, G., and J. E. de Vries. 1994. Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol. Today 15:19-26[CrossRef][Medline]. |
This article has been cited by other articles:
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»